Shuangcheng Pharmaceutical announced that the company's employee representative director and general manager Li JIANMING, and deputy general managers Yuan Jianlin, Ai Yixiang, and Wang Rui will expire on October 21, 2026. The aforementioned personnel reduced their holdings of the company's shares by a total of 354,500 shares through centralized bidding between September 21 and October 13, 2026, accounting for 0.08% of the company's total share capital. The plan previously disclosed by Deputy General Manager Yao Zhong to reduce his holdings has already been implemented. This reduction in holdings will not result in a change in the company's control and does not violate relevant commitments and regulations.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.